IMN-006

N/A

Report date: 2024/11/28 10:10:52

Base Information

Drug NameIMN-006
Drug Alias NameIMN-006
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 receptor modulators
TargetsTumor necrosis factor ligand superfamily member 13 receptor
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmuneel Therapeutics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmuneel Therapeutics Pvt Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A